Ann: CEO Presentation to Bioshares Conference, page-8

Ros Wilson has given the presentation...now we eagerly wait to see if the audience was inspired enough to buy...

I really hope Ros mentioned how tiny FTT's market cap is, especially after stripping out cash and ignoring the options which are well out of the money at the moment. It is like $35 m or something crazy. FTT's puny market cap is a critical piece of information that needs to be hammered home to would-be investors.

“For a lowly $35m enterprise value entry ticket, this is what you stand to gain, should the trial succeed....”

FTT is a compelling probability play.